marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
.
.
lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)
.
his heart, beating for 84 years and full of love for the woman he affectionately called his "blue-eyed guera [pronounced whedda]," felt like it was failing.
.
fda commissioner: it�s not a secret, sir. many experts know about it.
.
former novartis exec to lead cambridge diabetes startup semma
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
all programs
.
.
.activity
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
walter reed national military medical center in bethesda, maryland, would not give any details about why the first lady was still there.
activity
.
.